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Abstract 
The construction, characterization and surgical application of a multilayered iron oxide-based 
macroporous composite framework were reported in this study. The framework consisted of a 
highly porous iron oxide core, a gelatin-based hydrogel intermediary layer and a matrigel outer 
cover, which conferred a multitude of desirable properties including excellent biocompatibility, 
improved mechanical strength and controlled biodegradability. The large pore sizes and high 
extent of pore interconnectivity of the framework stimulated robust neovascularization and 
resulted in substantially better cell viability and proliferation as a result of improved transport 
efficiency for oxygen and nutrients. In addition, rat models with myocardial infraction showed 
sustained heart tissue regeneration over the infract region and significant improvement of cardiac 
functions following the surgical implantation of the framework. These results demonstrated that 
the current framework might hold great potential for cardiac repair in patients with myocardial 
infraction. 
Key words: macroporous frameworks; vasculature; stem cell; blood iron pool; cardiac repair. 
Introduction 
The advancement in material sciences, synthetic 
chemistry and nanotechnology has led to an explosion 
in the variety of frameworks available for tissue 
grafting [1]. Regardless of components used and 
structures adopted, the suitability of any implantable 
framework should always be assessed using the 
following set of criteria. The foremost requirement is 
that the framework must offer excellent 
biocompatibility, which is vital for effective cell 
adherence and prolonged cell viability [1]. Ideally, the 
micro-environment inside the framework should 
closely resemble the native extracellular matrix (ECM) 
of the cells and tissues to be grafted. Controlled 
biodegradability plays an equally important role in 
the selection and design of framework materials. The 









time frame that ensures sufficient expansion of the 
grafted tissue, and generate only non-toxic products 
that can be easily metabolized. 
Porous framework-based delivery of stem cells is 
an emerging treatment approach for patients with 
myocardial infarction (MI). The blockage of coronary 
arteries eventually results in irreversible necrosis of 
the affected heart tissues and severely impaired heart 
functions [1]. In the past decades, however, the direct 
injection of neonatal rat cardiomyocytes followed by 
rapid cell death during the first week leads to the 
approximate loss of 90% of the total cell population 
introduced [2]. Furthermore, these unattached cell 
grafts are also at the risk of being washed away due to 
the high compressive forces present in the cardiac 
chambers [2].  
Compared to the methods that attempt to 
directly inject a suspension of stem cells or 
cardiomyocytes to the infract zone, the primary 
advantage of using of an implantable framework is its 
ability to mimic the architecture of the extracellular 
matrix. The ECM is generally considered to be 
essential for cell differentiation and proliferation. 
Therefore, by being adhered to and insulated by the 
porous framework would allow stem cells and 
cardiomyocytes to be physically sequestered at the 
target area and maximize their chances of retention. 
Past studies have also suggested the benefit of 
inducing a mild inflammatory response in the course 
of framework degradation to stimulate cell 
proliferation [3, 4]. Another determinant in 
framework fabrication is the creation of a highly 
porous, interconnected architecture that allows 
efficient diffusion of nutrients and metabolic wastes. 
The pore size of the framework is particularly crucial 
for cardiac tissue engineering due to a high demand 
of vascularization [5]. A delicate balance should be 
maintained between promoting unrestricted cell 
migration and avoiding excessive internal space that 
would slow down microvasculature formation [6]. 
The development of novel implantable 
frameworks should meet all requirements mentioned 
above. It is inevitable that many frameworks fare well 
in some metrics and underperform in others. For 
example, frameworks comprising naturally occurring 
polymers, such as collagen [7, 8], gelatin [9], chitosan 
[10] and other types of polysaccharides and 
polypeptides [11], are generally quite biocompatible 
and biodegradable. However, they still suffer 
significant drawbacks that include poor mechanical 
integrity, potential immunogenicity, and a lack of 
tailoring techniques [12]. The alternative is a host of 
synthetic polymers poly(glycerol sebacate) (PGS) [13], 
poly(lactide-co-glycolide) (PLGA) [14], poly(ethylene 
glycol) (PEG) [15, 16], or others [17]. Synthetic 
frameworks are generally less susceptible to fracture, 
offer more customizability, and often elicit a lower 
level of undesirable immune response from the host. 
However due to their artificial nature, they often 
underperform their natural counterparts in serving as 
a suitable anchorage for cell attachment and growth. 
Research efforts have thus been increasingly focused 
on generating composite frameworks to combine the 
strengths of natural and synthetic materials. Fibrous 
frameworks consisting of poly(lactic-co-glycolic acid 
(PLGA), gelatin and α-elastin were found to induce 
better three-dimensional (3D) tissue assembly and cell 
ingrowth with improved mechanical strength [18]. 
More recently, carbon nanofibers were incorporated 
into a chitosan-based framework, leading to better 
conductivity and simultaneous increase in graft 
viability [19]. Despite these advances, it is often 
technologically challenging to create frameworks that 
excel in all desirable metrics, including satisfactory 
biocompatibility, porosity, malleability, and so on. 
More importantly, to the best of our knowledge, there 
has been no concrete experimental data that directly 
evaluate the surgical benefits of tissue engineering 
frameworks. The lack of clinical consideration in these 
studies often leads to the development of tissue 
engineering frameworks that demonstrate 
laboratory-proven success but eventually fail to 
exhibit efficacy in real surgical applications. 
In the past several years, we have focused on the 
development of macroporous materials that exhibited 
the potential of application in the field of tissue 
engineering [20, 21, 22]. Especially, we find the way to 
construct frameworks based on composite materials, 
which paves the way for satisfying biomedical needs 
[23]. Herein, we report a multi-layered iron oxide 
framework that contains a gelatin-based hydrogel 
intermediary layer and a matrigel outer cover (Figure 
1). Combining the respective strengths of the 
individual materials, the framework possesses a 
hierarchical porous structure that promotes robust 3D 
cell proliferation and vascularization, and exhibits 
excellent biocompatibility allowing facile cell 
adhesion. More importantly, the composite 
framework also showed a high efficiency in 
regenerating heart tissues in vivo and restoring lost 
cardiac functions for rats with myocardial infraction 
(increased ~ 63% of stroke volume, ~ 32% of ejection 
fraction, ~ 49% of fraction shortening). The composite 
framework constructed in current study combined the 
advantages of natural and synthetical materials and 
owned the potential to release iron ion which may be 
beneficial in curing myocardial infract ion. We 
envision that this study could pave the way for new 
development in porous material-based heart tissue 
engineering frameworks in future. 






Figure 1. Schematic of the construction of macroporous iron oxide frameworks for efficient regeneration and repair of infracted heart. 
 
Materials and Methods 
The synthesis of macroporous iron oxide 
frameworks 
The construction of an ultralight magnetic 
framework was obtained by controlled hydrolysis of 
K4[Fe(CN)6] over a polyurethane (PU) sponge to form 
prussian blue nanocubes, followed by atmospheric 
pyrolysis that formed macroporous iron oxide 
structures [24]. Polyurethane (PU) sponges with 
various pore sizes per linear inch (PPI) were used as a 
macroporous scaffold for 3D growth of PB. In a 
typical procedure, 127 mg (0.3 mmol) 
K4Fe(CN)6•3H2O was added to a 80 mL solution of 
0.05 M hydrochloric acid (HCl) and stirred for 60 min, 
followed by the slow, controlled immersion of a 30 
cm3 PU sponge. The resulting mixture was heated to 
85 ºC and maintained at this temperature for 48 h. The 
framework, then coated with Prussian blue, was dried 
in a vacuum oven at 40 ºC for 12 h and then subjected 
to pyrolysis at (350, 400, and 450 C) with a temperate 
ramp of 1 C min-1 for 3 h. To remove the remnants 
K4Fe(CN)6•3H2O, Prussian blue and PU, as well as 
various by-products generated in the fabrication 
process, the iron oxide framework was dialyzed in 10 
mL DMSO for 7 days and then in sterile ultrapure 
water for an additional 7 days. During dialysis, the 
dialysis buffer was changed every 24 h. The treated 
framework was then immersed for 2 h in a 2 mL 
sterile solution of 2% gelatin, which was briefly 
sonicated to remove all the air bubbles. The 
gelatin-coated framework was subsequently allowed 
to dry in a sterilized ventilation hood. 
Cell Seeding  
Bone-marrow-derived rat mesenchymal stem 
cells were isolated from rat shin bones and transfected 
with an eGFP-carrying lentiviral vector. The 
transfected cells were seeded on the gelatin-layered 
framework at a concentration of 3×107 per mL, with a 
total volume of 0.5ml mL of cell suspension used. The 
seeded framework was placed in a clean, sterile petri 
dish and was incubated at 37 ºC for 6 h to allow cell 
attachment, after which the framework was rinsed 3 
times with a combined volume of 15 mL of Dulbecco's 
Modified Eagle's medium (DMEM), supplemented 
with 10% fetal bovine serum (FBS), 1% 
Penicillin-Streptomycin, in order to remove 
unattached cells. The framework was next placed in 3 
mL of fresh DMEM medium supplemented with 10% 
FBS and 1% Penicillin-Streptomycin and cultivated at 
37 ºC and under 5% CO2 over a period of 7 days, 
during which period the abovementioned medium 
was changed on a daily basis. 
Structural Characterization 
The field emission scanning electron microscopy 
(FESEM) images were carried out on a FE-SEM S-4800 
scanning electron microscope (Hitachi, Japan). 
Confocal fluorescent microscopy images were 
acquired using a Leica Confocal 1P/FCS microscope.  





Matrigel Coating  
 Once imaging experiments had confirmed the 
extensive proliferation of the seeded cells, the 
framework was carefully placed within a clone ring 
on a clean, sterile petri dish. The clone ring was filled 
with 200 μL pre-chilled 10% matrigel solution, 
allowed to stand for 15 sec and then drained of the 
solution with the help of a pipette tip. This procedure 
was subsequently repeated for 20%, 40%, 80% and 
100% matrigel solutions. After the addition of the 
100% matrigel solution, the clone ring was incubated 
at 37 ºC for 2 h to allow the matrigel to solidify and 
form the outer layer of the composite framework. 
Framework Implantation  
 Surgical implantation of the iron-oxide-based 
composite framework onto the heart of healthy rats 
was performed based on a previously described 
protocol with minor modifications i . The rat was 
anesthetized with 2% isoflurane using an induction 
chamber and placed in a supine position. A midline 
cervical incision was performed to separate the skin, 
muscle and tissue that covered the trachea. After the 
exposure of the trachea, a small hole was created into 
the tissue between two cartridge rings below the 
glottis to insert the endotracheal tube with micro 
surgical forecepts. Once the lungs were verified to be 
well ventilated with a respiration rate (RR) of around 
110 per minute and an inspiratory pressure of 17-18 
cm H2O, the mouse was repositioned to allow it to lie 
on its right side and face left. A left-sided thoracotomy 
was performed between the 3rd and the 4th rib. Once 
the throax was opened, the part of the pericardial sac 
covering the heart was carefully removed without 
scratching and damaging the lungs, after which the 
framework was gently attached to the apex of the 
heart through the application of fibrin sealant (RAAS, 
Shanghai, China). Subsequently, a chest tube (28G, 
venal catheter) was placed between the 4th and the 
5th rib and the thoracic incision was closed, using 6-0 
Prolene running sutures (Ethicon, Norderstedt, 
Germany) to adapt the ribs and 4-0 Prolene running 
sutures (Ethicon, Norderstedt, Germany) to close the 
skin. Once complete, the thorax was drained with a 2 
mL syringe and the rat was placed on its back again to 
facilitate the removal of the endotracheal tube from 
the trachea, followed by adaptation of the tracheal 
cartridge rings in one single stitch using 7-0 Prolene 
sutures (Ethicon, Norderstedt, Germany). Finally, the 
skin was closed using 4-0 Prolene running sutures 
(Ethicon, Norderstedt, Germany). 
Myocardial Infarction Model  
For inducing MI in rats, the identical surgical 
procedures as implantation surgery were followed, 
except that once the pericardial sac covering the rat 
heart was removed, the left anterior descending artery 
(LAD), located between the pulmonary artery and the 
left auricle, was identified and its proximal segment 
was ligated with one single suture. The treated rats 
received cell-seeded framworks as the implantation 
surgery described and the control rats received sham 
operation. 
Echocardiography 
Rats were anesthetized by inhaled isoflurane 
(1%, Baxter) in normal air. Each animal was fastened 
to a heating pad and subject to a chemical hair 
remover (VEET, China) to shave the chest. 
Pre-warmed untrasound gel (Hankang, China) was 
utilized to the thoracic wall to facilitate the visibility 
of the heart chambers. Ecocardiography (M-model 
and two-dimensional) was performed by a Vevo 2100 
high resolution ultrasound machine. 
Statistical analysis 
 All data are derived from the mean of duplicate 
samples from three independently performed 
experiments and expressed in the format of mean ± 
_SEM. Statistical analysis was performed using SPSS 
(Version 20.0; IBM Corporation, Armonk, NY, USA) 
via either analysis of variance or Student–Newmann– 
Keuls multiple comparison test. Differences were 
considered statistically significant at P,0.05. 
Results 
The characterization of macroporous iron 
oxide frameworks 
As illustrated in Figure 2, the clean, sterile iron 
oxide framework was visualized to possess an 
interconnected porous structure. However, the 
pristine porous iron oxide framework showed poor 
biocompatibility with mesenchymal stem cells in 
subsequent cell adhesion assays (data not shown). As 
evidenced by the scanning electron microscope 
(SEM), the gelatin-based hydrogel layer significantly 
smoothed the surface of the iron oxide core, and 
improved the cell adhesion efficiency. 
Macroporous iron oxide frameworks support 
cellular proliferation and migration 
The number of viable cells was monitored by 
measuring the fluorescence generated by 
lentivirus-promoted enhanced green fluorescent 
protein gene transduction. Imaging of the porous 
framework at 24 h after seeding revealed sporadic 
fluorescence over its outer surface and further 
indicated successful cell adhesion (Figure 3a). At Day 
3, fluorescent cells were observed to have grown 
extensively along the trabeculae and also started to 





penetrate into the pores on the framework (Figure 
3b). At Day 7, the proliferated cells had both 
completely covered the outer surface of the 
framework and filled up its porous core (Figure 3c). 
The formation of an extensive 3D cell network was 
further confirmed by confocal microscopy and 3D 
image reconstruction (Figure 3d, e). In addition, the 
cross-section of the framework was visualized by 
SEM images, which provided unambiguous evidence 
of cell growth at a depth of 1.5 mm to the surface 
(Figure 3f). SEM images of a single pore and its 
surroundings revealed entanglement of thick cell 
sheets around the frame of the pore (Figure 3g). It is 
especially noteworthy that the large and highly 
interconnected pores of the framework allowed the 
existence of microchannels, which could ensure 
unfettered nutrient transfer and vascularization, even 
after the cells had completely enveloped the 
trabeculae (Figure 3g). Taken together, these imaging 
results indicated the ability of the framework to 
promote rapid in vitro regeneration of myocardial 
cells and vasculature. 
Matrigel coating increases the compatibility 
with surgery 
Frameworks loaded with stem cells are 
vulnerable to the procedures of surgery, which may 
be similar with the failure of vein graft caused by 
injury during surgery [25]. Depending on the specific 
circumstances, this could be attributed to the physical 
damage of the cells during surgical handling, 
dehydration due to prolonged exposure to air, and so 
on. In many cases, an additional protective layer is 
warranted outside the regenerated cells to shield them 
from these detrimental factors. After allowing seeded 
stem cells to grow for 3 days, the framework was 
coated with a homogenous layer of the matrigel. As 
illustrated in Figure 4, the matrigel cover did not 
diminish the fluorescence level of the cells on the 
framework, indicating that they remained 
metabolically robust. 
Cell-seeded macroporous iron oxide 
frameworks mitigate the ischemia-induced 
heart dysfunction 
The composite porous framework was 
subsequently implanted into healthy rats to ascertain 
whether the regenerated myocardial cells and blood 
vessels could continue to grow and form functionally 
competent tissue network in vivo. The structural 
integrity of the implanted framework was first 
monitored via magnetic resonance imaging (MRI). 
Immediately following the implantation, the presence 
of the framework was shown to lead to a decline of T2 
signal at the target zone (Figure 5a). After 2 months, 
subsequent MRI imaging revealed near-complete 
shrinkage of the low-T2 area around the same zone 
(Figure 5b), implying that the framework had been 
largely absorbed. Close examination of the area where 
the framework was implanted under a stereo 
fluorescent microscope found a significantly higher 
level of fluorescence intensity (Figure 5c) compared to 
the background of nonspecific fluorescence emanated 
by the framework-free control (Figure 5d), suggesting 
a sustained growth of the grafted tissues on the 
heart’s surface (the relevant histological result was 
shown as Supplement Figure 1). 
 
 
Figure 2. SEM images showing the naked iron oxide framework (a), the gelatin-coated framework (b), and stem cells adhering to and proliferating around the 
framework trabeculae (c); demonstrating the surface features of the naked iron oxide framework (d) and the gelatin-coated framework (e). It can be seen that the 
gelatin layer significantly smoothened the surface of the framework. 






Figure 3. Fluorescence microscopic images showing the proliferation of stem cells in one day (a), three days (b) and seven days (c) after seeding onto the framework; 
Confocal imaging and 3D reconstruction indicating the extensive cell proliferation around and inside the framework at Day 7 (d, e); SEM images acquired at a depth 
of 1.5 mm to the surface (f), a thick layer of robustly proliferated cells can be seen enveloping the frame of the pore (g). The microchannel is clearly visible at the center 
of the pore and surrounded but otherwise unhindered by the proliferated cells. 
 
Figure 4. Light microscopic (a) and fluorescent microscopic (b) images of the matrigel-coated framework, demonstrating the continued viability of the cells after the 
coating; A close-up of the matrigel layer at the surface of the framework, as indicated by the green arrows. Both the light microscopic (c) and fluorescent microscopic 
(d) images are shown.  






could also be clearly observed 
around the implanted area, which 
was indicated by the 
corresponding shadows cast in the 
fluorescent field of view (Figure 
5c). The beneficial effect of the 
matrigel cover on the viability of 
the implanted cells was 
demonstrated by a control 
experiment in which a 
matrigel-free framework was used 
for implantation (Figure 5e). As a 
consequence, the fluorescence 
intensity around the implanted 
area was on average 61% lower 
compared to when a 
matrigel-covered framework was 
employed (Figure 5f). In addition, 
the effect of the implanted 
framework on heart functions was 
tested on rats with myocardial 
infract ion using echocardiogram. 
Compared to the control that did 
not receive any implant, rats with 
myocardial infract ion that were 
implanted with the framework 
showed a significant 
improvement in several aspects of 
cardiac functions, including stroke 
volume (fold-change = 1.63, P < 
0.05), ejection fraction 
(fold-change = 1.32, P < 0.05) and 
fraction shortening (fold-change = 
1.49, P < 0.05) (Figure 5g-l). These 
results indicated that the 
composite framework that we 
developed could indeed 
effectively promote heart tissue 
regeneration and considerably 
improve the performance of the 
infract heart in rat models. 
Discussion 
To the best of our 
knowledge, the study described 
herein constitutes the first 
example of using an 
iron-oxide-based framework for 
tissue engineering. As an 
inorganic substance, iron oxide 
offers natural and highly 
tailorable porosity, excellent 
malleability and biodegradability. 
These features are some of the 
 
Figure 5. MRI scans showing the presence of the framework at the target area (indicated by the yellow 
arrow) immediately after the implantation (a) and the near-complete degradation of the framework in two 
months (b); fluorescence imaging of the target area on the heart where the framework was implanted: 
Significant growth of the implanted cells and regeneration of heart tissues can be seen two months after 
framework implantation (c) compared with he fluorescent background of the heart control with no 
framework implant (d); Matrigel-free framework showed low density of green fluorescence (e) compared to 
matrigel coating framework (f);Representative echocardiograms of a healthy rat (g), a rat with MI in which a 
framework was implanted (h), and a rat with MI as a control that did not receive any implant (i). Column 
charts comparing the stroke volume (j), ejection fraction (k) and fraction shortening (l) of the three 
abovementioned rat models. Bars represent standard error of mean. NS indicates no statistical significance. * 
P < 0.05.  





highly sought-after traits for tissue regrowth and 
implantation. Previously, the incorporation of 
inorganic materials in frameworks was almost 
entirely limited to various ceramics, hydroxyapatite 
(HA) or bioactive glasses, all of which are almost 
exclusively used in the regeneration of bone tissues 
[26, 27]. In contrast, no other type of inorganic 
framework or application of such framework in heart 
tissue engineering has been reported. The preparation 
of the iron oxide framework involved growing 
prussian blue nanotubes on a PU sponge via 
controlled hydrolysis of K4[Fe(CN)6] and then 
submitting them to pyrolysis. This fabrication method 
exploits the high tailorability of the prussian blue 
template and is easily scalable at low cost [28]. In 
contrast, the size, shape and microscopic architecture 
of frameworks constructed from natural bioorganic 
materials are often restricted by the intrinsic 
mechanical and biological properties of the donor 
tissues or organs [29]. The generated iron oxide 
framework is characterized by its ultralight and 
porous architecture, which makes it particularly 
applicable to tissue regeneration and surgical 
implantation. 
The availability of an interconnected porous 
architecture inside the framework plays a vital role in 
many essential functions, including nutrient transfer 
and 3D cell migration [13, 29], particularly for heart 
tissue grafting and vascularization [30]. To facilitate 
cell invasion into the interior framework, a careful 
calibration of the pore size has been conducted. The 
average pore size of a heart tissue framework needs to 
start in the vicinity of a few tens to hundreds of 
microns to accommodate myocardial and endothelial 
cells, with average sizes of 10 – 100 μm and 8 – 12 μm, 
respectively [31, 32]. When only surface 
neovascularization is concerned, the optimal pore size 
can be quite small [33]. But it is generally agreed that 
significantly larger pores between 100 and 500 μm are 
needed for the generation of extensive 3D vasculature 
networks, and this networks are thought to greatly 
increase the thickness and amount of tissues available 
for grafting [34]. For instance, an assessment of vessel 
invasion efficiency for various types of PEG-based 
hydrogels yielded the finding that pores with an 
average size of 100 – 150 μm resulted in considerably 
more extensive vessel generation inside the 
framework and a greater invasion area compared to 
the framework with pore sizes between 25 – 50 μm 
[35]. In this study, the results of SEM and fluorescent 
imaging demonstrated that the choice of iron oxide as 
the framework core material could conveniently lead 
to an average pore size around 200 μm, which 
promoted an extensive cell proliferation within a 
period of 4-7 days following the seeding. Moreover, 
the large pores allowed the microchannels to remain 
generally unhindered, which would be beneficial for 
vascularization at the interior of the tissue framework. 
It should be emphasized that the porous network of 
our framework was also characterized by its high 
extent of interconnection. It has been reported that 
hydrogel-based frameworks with greater pore 
interconnectivity could exhibit twice as much 
invasion of proliferated cells inside the core compared 
to the ones with a similar distribution of pore size but 
fewer interconnections [36]. Consistent with these 
results, we found unambiguous evidence of cell 
ingrowth at a depth of 1.5 mm to the surface of the 
framework. The oxygen and nutrients that sustained 
the living cells at the depth of 1.5 mm should be 
facilitated by the porous structure instead of simple 
diffusion. This was supported by the finding that 
growth of tumor cells was limited to a maximum 
range of approximately 0.4 mm in the absence of 
blood vessel formation [37]. Taken together, the high 
porosity and interconnectivity of our framework 
promoted neovascularization and concomitantly 
allowed the cells to penetrate deeper as a result of 
better oxygen and nutrient transport. 
In addition to the iron oxide core, we applied 
two additional layers of natural polymers that 
respectively comprised gelatin and matrigel. As 
thoroughly investigated in many other tissue 
engineering (TE) studies, gelatin displays excellent 
biocompatibility for enhancing cell adhesion and 
viability [38]. Indeed, the application of a 
gelatin-based intermediary layer exerted a potent 
surface-refining effect on the iron oxide framework 
that was initially not very conducive to cell adhesion. 
Importantly, the SEM imaging indicated that the 
gelatin layer did not significantly alter the porosity 
characteristics of the framework core, as the average 
pore size and the degree of interconnectivity 
remained roughly unchanged after the gelatin 
application. In addition, the matrigel-comprised outer 
cover was introduced not only for the purpose of 
improving the mechanical toughness of the 
framework and further increasing its biocompatibility 
with the infract region, but also for additional reasons 
with practical ramifications in surgery. First, the 
matrigel served as a protective layer against the 
external environment, particularly against potential 
sources of physical damage such as improper 
handling during surgery. Second, bathing the 
framework successively in increasingly concentrated 
matrigel solutions helped completely expel air 
bubbles from its porous interior. Since air trapped 
inside the pores is detrimental to both cell hydration 
and framework sterilization, matrigel envelopment of 
the framework could improve overall cell viability 





and contribute to the robust spreading of graft tissues 
after implantation. Indeed, the use of a control 
framework lacking matrigel protection led to a 
substantial decrease in the number and density of 
viable myocardial cells, as indicated by fluorescence 
measurement, after in vitro incubation and surgical 
implantation. It should also be pointed out that 
compared to synthetic organic materials such as 
polylactic acid and polyglycolic acid, the gelatin and 
matrigel layers could provide more protein loci that 
facilitate cellular adhesion and migration [29]. 
A significant advantage of our study design was 
that the porous structure of our composite 
frameworks had the ability to sustain 
three-dimensional cell proliferation in vivo and in 
vitro. Moreover, the implantation experiments 
enabled us to directly monitor the biodegradability of 
our framework, a trait that is medically important but 
generally cannot be accurately evaluated via in vitro 
assays. In fact, disc-shaped PLGA frameworks that 
were implanted subdermally on rats were found to 
degrade faster than when subjected to in vitro 
degradation conditions[39]. In this study, the MRI 
scan suggested a near-complete degradation of the 
framework within two months. It should be noted 
that the moderate degradation rate of our composite 
framework allowed sufficient time for the integration 
of graft tissues and vasculature. Balancing 
degradation with porosity is a major technical concern 
in framework fabrication, as the high surface area of a 
porous framework, which is needed for cell 
proliferation, often results in its premature absorption 
after implantation[40]. The presence of multiple 
functional layers and the chemical nature of iron 
oxide played important roles in delaying the 
degradation of our framework in vivo. 
After implantation, the mechanical force of heart 
contraction would cause the iron oxide core of the 
framework to disintegrate into particles, which would 
be phagocytized by macrophages and subsequently 
metabolized into soluble iron ions. The iron species 
could be stored in the form of ferritin or hemosiderin, 
or alternatively, released into the circulatory system 
and transported back to the marrow. The metabolism 
of iron derived from iron oxide nanoparticles has 
previously been investigated using Fe-labeled 
ferumoxytol [41]. It was found that iron was 
overwhelmingly retained, while organic components 
such as the carbohydrate coating were excreted [42, 
43]. Due to the crucial role of iron in maintaining the 
viability of red blood cells, intravenous 
administration of iron-containing agents has been 
applied with success to the treatment of various 
anemia-related symptoms. For example, Garcia-Erce 
et al reported that intravenous injection of iron 
sucrose significantly improved the hemoglobin levels 
and reduced the occurrence of anemia in patients 
undergoing knee replacement surgery [44]. Similar 
positive effects were also observed in a clinical study 
conducted by Toblli and co-workers, where 
substantially better cardiac and renal function 
parameters were associated with increased blood iron 
availability [45]. Furthermore, iron supplementation 
was also demonstrated to be beneficial for infract 
reduction and left ventricular remodeling in patients 
with acute ST-elevation myocardial infraction [46]. 
Although the exact mechanism was unclear, the 
positive effect of iron was thought to be associated to 
its potential roles in stimulating the generation of 
mitochondrial adenosine triphosphate and/or 
eliciting anti-inflammatory response in macrophages 
that accelerated myocardial repair [47, 48]. These 
results suggested that the choice of iron oxide as the 
building material of the framework could potentially 
improve post-operative recovery of cardiac function 
in patients with myocardial infract ion. 
In summary, we have developed implantable 
and biodegradable macroporous framework 
consisting of an iron oxide core covered by a gelatin 
mid-layer and a matrigel outer layer. The framework 
was observed to possess a highly interconnected, 
porous architecture, high surface area (~ 85 m2/g) 
with an average pore size of 200 μm suitable for 3D 
tissue growth and vascularization. The seeded rat 
mesenchymal stem cells, sandwiched between the 
gelatin and the matrigel layers, demonstrated 
effective adhesion along the framework trabeculae 
and significant invasion into its porous interior within 
4 to 7 days. Heart implantation experiments 
performed on healthy and infract rats generated 
sufficient evidence for the framework’s excellent 
biodegradability and effectiveness in promoting heart 
tissue regeneration in vivo. This work showcased a 
new approach using functional multilayer 
macroporous frameworks to effectively regenerate 
heart tissue in vivo and restore lost cardiac functions. 
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